Corporate | 30 May 2011 07:30
4SC AG / Key word(s): Miscellaneous
30.05.2011 / 07:30
Planegg-Martinsried, Germany - 30 May, 2011 - 4SC AG (Frankfurt, Prime
Standard: VSC), discovers and develops targeted small molecule drugs for
autoimmune and cancer diseases, today announced that Enno Spillner, CFO at
4SC, will attend the Jefferies 2011 Global Healthcare Conference, which is
held from 6-9 June in New York, USA. The presentation slot for 4SC will be
on 9 June at 9.30am.
For further information please contact:
4SC AG
Yvonne Alexander
Investor Relations & Public Relations
Tel: +49 (0) 89 70 07 63 66
yvonne.alexander@4sc.com
The Trout Group (USA)
Chad Rubin
Tel: +1 646 378 2947
crubin@troutgroup.com
Notes to Editor
About 4SC
4SC (ISIN DE0005753818) discovers and develops targeted, small-molecule
drugs for the treatment of diseases with a high unmet medical need in
various autoimmune and cancer indications. These drugs are intended to
provide patients with innovative treatment options that are more tolerable
and efficacious than existing therapies, and offer a better quality of
life. The company's balanced pipeline comprises promising products that are
in various stages of clinical development. 4SC's aim is to generate future
growth and enhance its enterprise value by entering into partnerships with
leading pharmaceutical companies.
Founded in 1997, 4SC currently has 94 employees and has been listed on the
Prime Standard of the Frankfurt Stock Exchange since December 2005.
Legal Note
This document may contain projections or estimates relating to plans and
objectives relating to our future operations, products, or services; future
financial results; or assumptions underlying or relating to any such
statements; each of which constitutes a forward-looking statement subject
to risks and uncertainties, many of which are beyond our control. Actual
results could differ materially, depending on a number of factors.
End of Corporate News
---------------------------------------------------------------------
30.05.2011 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: 4SC AG
Am Klopferspitz 19a
82152 Martinsried
Deutschland
Phone: +49 (0)89 7007 63-0
Fax: +49 (0)89 7007 63-29
E-mail: public@4sc.com
Internet: www.4sc.de
ISIN: DE0005753818
WKN: 575381
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, München, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
126655 30.05.2011